Evidence map›Paper›PMID 41291857›Full record

ArticleReproductive health2025

Addressing unmet needs in pregnancy and family planning of people living with rare and low-prevalence diseases: results of the "ERN transversal working group on pregnancy and family planning" survey.

Giovanni Fulvio, Diana Marinello, Dina Zucchi, Silvia Aguilera, Alexandra Benachi, Ruth Biller, Ignacio Blanco, Marie-Claude Boiteux, Petra Borgards, Maria Luisa Brandi and 37 more

Abstract read
In one paragraph

Article in Reproductive health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

Giovanni Fulvio *Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Diana Marinello *Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Dina ZucchiRheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Silvia AguileraERN ReCONNET, Pisa, Italy.
Alexandra BenachiService de Gynecologie Obstetrique, Hopital Antoine Béclère, AP-HP, Université Paris Saclay, Clamart, Paris, France.
Ruth BillerARVC-Selbsthilfe e.V, Monaco, Germany.
Ignacio BlancoDepartment of Clinical Genetics, Laboratori Clinic de la Metropolitana Nord, Germans Trias i Pujol, Badalona, Badalona, Spain.
Marie-Claude BoiteuxCutis Laxa Internationale, Bons-en-Chablais, France.
Petra BorgardsBundesverband Angeborene Gefäßfehlbildungen e.V, Mülheim an der Ruhr, Germany.
Maria Luisa BrandiVita-Salute San Raffaele University, Milan, Italy.
Ester CostafredaERN GUARD-Heart, Amsterdam, Netherlands.
João E FonsecaERN ReCONNET, Pisa, Italy.
Micaela FrediERN ReCONNET, Pisa, Italy.
Vera GuimarãesERN ReCONNET, Pisa, Italy.
Violeta IotovaDepartment of Pediatrics, Medical University, Varna, Varna, Bulgaria.
Estelle Lecointe-ArtznerEURACAN, Lyon, France.
Ana Rita LopesERN ReCONNET, Pisa, Italy.
Simone LouisseERN GUARD-Heart, Amsterdam, Netherlands.
Cecilia NalliERN ReCONNET, Pisa, Italy.
Marzena OlesinskaERN ReCONNET, Pisa, Italy.
Michela OnaliERN EURO-NMD, Paris, France.
Wiebke PapenthinMorbus Wilson e.V, Kürnach, Germany.
Beverley PowerERN ERNICA, Rotterdam, Netherlands.
Claas RöhlERN GENTURIS, Nijmegen, Netherlands.
Christine Rousset-JablonskiEURACAN, Lyon, France.
Dominique SturzUsher Initiative Austria, Vienna, Austria.
Angela TincaniERN ReCONNET, Pisa, Italy.
Carine Jm der van VleutenVASCERN, Paris, France.
Ana VieiraERN ReCONNET, Pisa, Italy.
Dorica DanRomanian Prader Willi Association, Romanian National Alliance for Rare Diseases RONARD, Zalău, Romania.
Julie De BackerVASCERN, Paris, France.
Christina de Die SmuldersERN EURO-NMD, Paris, France.
Andreas DufkeERN ITHACA, Paris, France.
Charissa FrankERN ReCONNET, Pisa, Italy.
Giuseppe LimongelliERN GUARD-Heart, Amsterdam, Netherlands.
Birgit LorenzERN EYE, Strasbourg, France.
Elisa KilpiäinenERN CRANIO, Rotterdam, Netherlands.
María Jesús PascauPaediatric Transplant Unit, La Paz University Hospital, Madrid, Madrid, Spain.
Johanna RaidtDepartment of General Pediatrics, University Hospital Muenster, Muenster, Germany.
Isabelle Ray-CoquardEURACAN, Lyon, France.
Rachel RimmerERN RITA, Utrecht, Netherlands.
Holm SchneiderERN Skin, Paris, France.
Helena J der Van PalPrincess Máxima Center for pediatric oncology, Utrecht, Netherlands.
Tet YapGuy's and St Thomas' NHS Trust, London, United Kingdom.
Rosaria TalaricoRheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Chiara TaniRheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Marta MoscaRheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. marta.mosca@unipi.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPregnancy and family planning for individuals living with rare and low prevalence diseases present unique medical, psychological, and logistical challenges. The European Reference Networks (ERNs) were established to address healthcare disparities and enhance patient care for rare diseases across Europe. The ERN Transversal Working Group on Pregnancy and Family Planning was created to identify common unmet needs and to develop targeted actions to improve healthcare delivery. As part of this initiative, a survey was conducted to gather insights from patients, caregivers, and family members about their experiences and challenges related to pregnancy and family planning.

methodsThe survey was co-designed by healthcare professionals and patient representatives from 20 ERNs. It covered various domains, including fertility preservation, pre-conceptional counselling, psychological support in the pre-conceptional counselling, pre-implantation diagnosis, prenatal diagnosis, family planning, pregnancy monitoring, post-pregnancy monitoring, lactation and newborn management. The survey, available in multiple languages, was distributed via online platforms between February and July 2022. Quantitative responses were analysed descriptively, while qualitative data from open-ended questions were processed using word frequency analysis.

resultsA total of 769 responses were collected, with 574 from patients and 155 from caregivers. The majority of respondents were female (90%) and aged 31-40 years, primarily from Germany, France, Spain, and Italy. The most pressing concerns identified included lack of access to accurate medical information, limited psychological support, inadequate pre-conceptional counselling, and challenges related to pregnancy monitoring and postpartum care. The need for multidisciplinary healthcare teams and improved education on reproductive health was emphasised. Word frequency analysis highlighted key concerns, with "inform," "support," and "risk" being the most recurrent terms.

conclusionsThis study underscores the widespread need for comprehensive, patient-centred approaches in pregnancy and family planning for individuals with rare and low prevalence diseases. Improved access to specialised healthcare teams, psychological support, and clear, standardised medical information is essential. These findings advocate for the development of harmonised European policies and multidisciplinary strategies to enhance reproductive healthcare. People living with rare diseases often face extra challenges when it comes to pregnancy and family planning. To better understand these issues, a group of experts and patient representatives from 20 European Reference Networks (ERNs) worked together to conduct a survey. A European survey of 769 people, mostly women aged 31 to 40 from Germany, France, Spain, and Italy, revealed significant gaps in care. The most common concerns shared by patients included difficulty finding clear medical information, not enough psychological support, gaps in counselling, and challenges with checking on health during and after pregnancy. Many felt that better teamwork among different healthcare providers and improved education on reproductive health would make a big difference. In summary, this study underscores the urgent need for better reproductive healthcare for people with rare diseases.

Indexed as

Family Planning ServicesHealth Services Needs and DemandRare DiseasesAdultEuropeFemaleHumansMaleMiddle AgedPregnancyPrevalenceSurveys and QuestionnairesPatient-centered care european reference networks (ERN)PregnancyPsychological supportRare diseasesReproductive healthUnmet needs

Identifiers

PMID41291857
PMCPMC12648893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.